Post date July 27, 2023 Experience Upgrade $100 million acquisition of Uplift We advised Upgrade on the transaction
Post date June 28, 2023 Experience Centogene strategic collaboration with Lifera We are advising Centogene on its joint venture with and convertible debt investment by Lifera
Post date May 12, 2023 Experience Estée Lauder $2 billion senior notes offering The investment-grade notes are due 2028, 2033 and 2053
Post date April 4, 2023 Experience TPG acquisition of majority stake in Thomson Reuters’ Elite business We are advising TPG on the transaction
Post date March 6, 2023 Experience Alteryx $450 million senior notes offering The 8.75% notes are due 2028
Post date February 10, 2023 Experience CureVac $250 million follow-on offering We advised CureVac on the equity offering
Post date January 27, 2023 Experience Precigen $75 million follow-on offering We advised Precigen on the SEC-registered offering
Post date December 7, 2022 Experience Ferrero Group acquisition of Wells Enterprises We are advising Ferrero on the transaction
Post date November 22, 2022 Experience Biodesix $40 million follow-on offering The shares are listed on the Nasdaq Global Market
Post date November 22, 2022 Experience TMS ¥2.9 billion global IPO The shares are listed on the Tokyo Stock Exchange